Abstract:figure legend A solid tumour schematic is shown on the right, highlighting enhanced or suppressed mitochondrial Ca2+ uptake in cancer. Enhanced mitochondrial Ca2+ uniporter complex (mtCU)‐mediated Ca2+ uptake (top) is implicated in colorectal cancer, breast cancer, oral squamous cell carcinoma, pancreatic cancer, hepatocellular carcinoma and embryonal rhabdomyosarcoma. Decreased mtCU‐mediated mitochondrial Ca2+ uptake (bottom) has been associated with melanoma but remains uncharacterized in glioblastoma. The mitochondrion shown above the tumour depicts enhanced mitochondrial Ca2+ uptake as a result of mtCU channels comprised of 3 × mitochondrial Ca2+ uniporter (MCU) (teal):1 × MCU dominant‐negative beta (MCUb) (violet):2 × essential MCU regulator (EMRE) (beige):1 × mitochondrial Ca2+ uptake (MICU)1 (green):1 × MICU2 (pink) subunits, with Ca2+ ions shown in grey. The mitochondrion shown below the tumour depicts suppressed mitochondrial Ca2+ uptake as a result of mtCU channels comprised of 1 × MCU (teal):3 × MCUb (violet) subunits. The dysregulated oncogenic/anti‐oncogenic microRNAs (miRNAs), small‐molecule inhibitors and post‐translational modifications correlated with mtCU‐mediated mitochondrial Ca2+ dysfunction are indicated as future avenues and considerations for therapeutic intervention. Created with BioRender.com. Increased malignancy and poor treatability associated with solid tumour cancers have commonly been attributed to mitochondrial calcium (Ca2+) dysregulation. The mitochondrial Ca2+ uniporter complex (mtCU) is the predominant mode of Ca2+ uptake into the mitochondrial matrix. The main components of mtCU are the pore‐forming mitochondrial Ca2+ uniporter (MCU) subunit, MCU dominant‐negative beta (MCUb) subunit, essential MCU regulator (EMRE) and the gatekeeping mitochondrial Ca2+ uptake 1 and 2 (MICU1 and MICU2) proteins. In this review, we describe mtCU‐mediated mitochondrial Ca2+ dysregulation in solid tumour cancer types, finding enhanced mtCU activity observed in colorectal cancer, breast cancer, oral squamous cell carcinoma, pancreatic cancer, hepatocellular carcinoma and embryonal rhabdomyosarcoma. By contrast, decreased mtCU activity is associated with melanoma, whereas the nature of mtCU dysregulation remains unclear in glioblastoma. Furthermore, we show that numerous polymorphisms associated with cancer may alter phosphorylation sites on the pore forming MCU and MCUb subunits, which cluster at interfaces with EMRE. We highlight downstream/upstream biomolecular modulators of MCU and MCUb that alter mtCU‐mediated mitochondrial Ca2+ uptake and may be used as biomarkers or to aid in the development of novel cancer therapeutics. Additionally, we provide an overview of the current small molecule inhibitors of mtCU that interact with the Asp residue of the critical Asp‐Ile‐Met‐Glu motif or through other allosteric regulatory mechanisms to block Ca2+ permeation. Finally, we describe the relationship between MCU‐ and MCUb‐mediating microRNAs and mitochondrial Ca2+ uptake that should be considered in the discovery of new treatment approaches for cancer.

Mitochondrial Calcium Uniporter As A Target of Microrna-340 and Promoter of Metastasis Via Enhancing the Warburg Effect

The Regulatory Mechanism and Biological Significance of Mitochondrial Calcium Uniporter in the Migration, Invasion, Angiogenesis and Growth of Gastric Cancer.

Mitochondrial calcium uniporter as biomarker and therapeutic target for breast cancer: Prognostication, immune microenvironment, epigenetic regulation and precision medicine

Abstract 2776: Mitochondrial Calcium Uniporter in Pancreatic Cancer Metastasis and Metabolic Stress Resistance

Spatial and single-cell explorations uncover prognostic significance and immunological functions of mitochondrial calcium uniporter in breast cancer

The mitochondrial Ca2+ channel MCU is critical for tumor growth by supporting cell cycle progression and proliferation

The clinical significance of mitochondrial calcium uniporter in gastric cancer patients and its preliminary exploration of the impact on mitochondrial function and metabolism

MICU2 up-regulation enhances tumor aggressiveness and metabolic reprogramming during colorectal cancer development

Mitochondrial Calcium Uniporter Promotes Cell Proliferation and Migration in Esophageal Cancer

MCU-dependent mitochondrial Ca 2+ inhibits NAD + /SIRT3/SOD2 pathway to promote ROS production and metastasis of HCC cells

Mitochondrial Ca2+ controls pancreatic cancer growth and metastasis by regulating epithelial cell plasticity

Progress in Understanding Mitochondrial Calcium Uniporter Complex‐mediated Calcium Signalling: A Potential Target for Cancer Treatment

MCU-induced mitochondrial calcium uptake promotes mitochondrial biogenesis and colorectal cancer growth

The mitochondrial calcium uniporter: Balancing tumourigenic and anti‐tumourigenic responses

Targeting the mitochondrial calcium uniporter inhibits cancer progression and alleviates cisplatin resistance in esophageal squamous cell carcinoma

The Micrornas Mir-373 and Mir-520C Promote Tumour Invasion and Metastasis

Mir-221/222 Promote Cancer Stem-Like Cell Properties and Tumor Growth of Breast Cancer Via Targeting PTEN and Sustained Akt/NF-κB/COX-2 Activation.

Role of microRNAs in the Warburg effect and mitochondrial metabolism in cancer.

Oncogenic miR-20b-5p contributes to malignant behaviors of breast cancer stem cells by bidirectionally regulating CCND1 and E2F1

Extracellular metabolic energetics can promote cancer progression

Mitochondrial Mir-181A-5p Promotes Glucose Metabolism Reprogramming in Liver Cancer by Regulating the Electron Transport Chain.